Analyst Price Targets — BLUE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 22, 2022 2:49 pm | Gena Wang | Barclays | $5.00 | $5.83 | Pulse 2.0 | Bluebird Bio (BLUE) Stock: $5 Target And Equal-Weight Rating |
| March 7, 2022 12:00 am | David Nierengarten | Wedbush | $6.48 | $2.88 | Pulse 2.0 | bluebird bio (BLUE) Stock: $10 Price Target And Neutral Rating |
| November 19, 2021 12:00 am | Cory Kasimov | J.P. Morgan | $14.00 | $10.70 | StreetInsider | bluebird bio (BLUE) PT Lowered to $14 at JPMorgan |
| November 12, 2021 12:00 am | Zhiqiang Shu | Berenberg Bank | $11.00 | $11.68 | StreetInsider | bluebird bio (BLUE) PT Lowered to $11 at Berenberg |
| November 8, 2021 12:00 am | Salveen Richter | Goldman Sachs | $10.00 | $10.70 | TheFly | Bluebird Bio (BLUE) downgraded to Sell from Neutral at Goldman Sachs |
| September 13, 2021 12:00 am | Joshua Schimmer | Evercore ISI | $25.00 | $11.84 | Investing | Evercore ISI Stick to Their Buy Rating for bluebird bio |
| August 10, 2021 12:00 am | John Newman | Canaccord Genuity | $20.00 | $12.97 | TheFly | Bluebird Bio downgraded to Hold from Buy at Canaccord |
| August 9, 2021 12:00 am | Benjamin Burnett | Stifel Nicolaus | $18.00 | $11.76 | TheFly | Bluebird Bio price target lowered to $18 from $31 at Stifel |
Latest News for BLUE
NEW YORK, April 28, 2026 /PRNewswire/ -- Blue Water Acquisition Corp. IV (NYSE: BWIV) ("BWIV"), a publicly listed special purpose acquisition company (the "Company"), today announced that it has entered into a letter of intent ("LOI") to acquire substantially all of Maha Capital AB ("Maha") subsidiaries inclusive of their respective assets and contracts expected to result in the formation of a publicly traded…
Transaction Expands Fulton's Presence in Attractive New Jersey Markets LANCASTER, Pa., April 1, 2026 /PRNewswire/ -- Fulton Financial Corporation (Nasdaq: FULT) ("Fulton") today announced the successful completion of its acquisition of Blue Foundry Bancorp (formerly Nasdaq: BLFY) ("Blue Foundry"), Rutherford, N.J.
NEW YORK--(BUSINESS WIRE)---- $OWL #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Blue Owl Capital Inc. (NYSE: OWL) failed to manage Blue Owl in an acceptable manner, breaching their fiduciary duties to Blue Owl, and whether Blue Owl and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the…
Discounted Offer is Well Below OBDC II NAV and Ignores Significant Capital Return Already Underway NEW YORK, March 13, 2026 /PRNewswire/ -- Blue Owl Capital Corporation II ("OBDC II") today announced that its Board of Directors (the "Board") has unanimously recommended that shareholders reject the unsolicited minority tender offer from Cox Capital Partners ("Cox") and Saba Capital Management, L.P. ("Saba") for up to…
NEW YORK--(BUSINESS WIRE)---- $OWL #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Blue Owl Capital Inc. (NYSE: OWL) failed to manage Blue Owl in an acceptable manner, breaching their fiduciary duties to Blue Owl, and whether Blue Owl and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BLUE.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.